Bio-Techne (TECH) Stock News
$TECH · NASDAQ · 1 stories in 30 daysBORSA has published 1 story on Bio-Techne (TECH) in the past 30 days, 1 of it high impact. BORSA’s news read on TECH is bullish at 58/100, −1 over 24 hours, based on 1 company event over the past 30 days. Bio-Techne’s next earnings report is scheduled for Wednesday, Nov 4.
The wire on $TECH
newest first · updated · direct subject stories onlyBio-Techne shareholders approve acquisition by Merck KGaA, Darmstadt, Germany
Bio-Techne shareholders voted to approve the company's acquisition by Merck KGaA, Darmstadt, Germany. The Hart-Scott-Rodino waiting period expired September 18. The deal is expected to close by late 2026 or early 2027, pending remaining regulatory approvals.
bullish 80 · impact 85